Calcineurin inhibitors
- Human trial1
Outcomes
1complement-amplified humoral rejection
no changein humans1
1 study
complement-amplified humoral rejection
no changein humans1
Calcineurin inhibitors have no effect on complement-amplified humoral rejection in humans.
“conventional calcineurin-based immunosuppression provides no meaningful coverage for these pathways.”
Reviewxenotransplantation
Clinical transplantation and research21 Sep 2026
Latest
Transplantation Proceedings
Immunosuppression using the mammalian target of rapamycin (mTOR) inhibitor everolimus: pilot study shows significant cognitive and affective improvement
Non-randomised trial in 9 peoplemTOR inhibitors